Connect with us

Health

Pfizer already working on COVID-19 vaccine targeting Omicron: CEO

Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the US drugmaker's CEO Albert Bourla said Monday.

Bourla told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and has reignited fears of a global wave of Covid-19 infections.

“I don't think the result will be the vaccines don't protect,” Bourla said.

For more coronavirus news, visit our dedicated page.

But the testing could show that existing shots “protect less,” which would mean “that we need to create a new vaccine,” Bourla said.

“Friday we made our first DNA template, which is the first possible inflection of the development process of a new vaccine,” he said.

Johnson & Johnson also said Monday that it is “pursuing an Omicron-specific variant vaccine and will progress it as needed.”

On Friday, Moderna, another leading Covid-19 vaccine maker, said it was developing a booster shot against the new variant.

Bourla likened the situation to the scenario earlier this year when Pfizer and its German partner BioNTech developed a vaccine in 95 days when there were concerns the previous formula would not work against Delta, though that version ultimately was not used.

The current vaccine is “very effective” against Delta, the executive said, adding that the companies expect to be able to produce four billion vaccine doses in 2022.

On Monday, the World Health Organization warned the new Covid-19 Omicron variant poses a “very high” risk globally.

Bourla said he was also “very confident” that Pfizer's recently unveiled antiviral pill would work as a treatment for infections caused by the mutations, including Omicron.

Among newly-infected, high risk patients treated within three days of the onset of symptoms, Pfizer's pill has been shown to cut hospitalization or death by nearly 90 percent.

For the latest headlines, follow our Google News channel online or via the app.

Read more:

Omicron poses ‘very high’ global health risk, countries must prepare: WHO

First image of Omicron shows many more mutations than Delta variant

WHO says PCR tests detect Omicron, new COVID-19 variant has higher reinfection risk

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

World Food Safety Day: ‘Nobody should die from eating food’

Every day, some 1.6 million people worldwide fall ill from eating contaminated food, which kills 420,000 people each year, two UN agencies said on Tuesday.

Continue Reading

Health

World must ‘work as one’ to end plastic pollution: Guterres

As international negotiators committed to hammering out a draft treaty by November on ending plastic pollution, the UN chief stressed in his message for World Environment Day on Monday, the importance of curbing the “catastrophic” consequences of waste plastics.

Continue Reading

Health

US state abortion bans ‘putting millions of women and girls at risk’

Millions of women and girls across the United States have suffered an alarming deterioration in access to sexual and reproductive healthcare, following the US Supreme Court decision overturning the constitutional right to abortion in June 2022, UN-appointed independent rights experts said on Friday.

Continue Reading

Trending